134 related articles for article (PubMed ID: 12445562)
1. Effect of bovine serum albumin on drug permeability estimation across Caco-2 monolayers.
Saha P; Kou JH
Eur J Pharm Biopharm; 2002 Nov; 54(3):319-24. PubMed ID: 12445562
[TBL] [Abstract][Full Text] [Related]
2. Effect of solubilizing excipients on permeation of poorly water-soluble compounds across Caco-2 cell monolayers.
Saha P; Kou JH
Eur J Pharm Biopharm; 2000 Nov; 50(3):403-11. PubMed ID: 11072198
[TBL] [Abstract][Full Text] [Related]
3. The impact of protein on Caco-2 permeability of low mass balance compounds for absorption projection and efflux substrate identification.
Liu T; Chang LJ; Uss A; Chu I; Morrison RA; Wang L; Prelusky D; Cheng KC; Li C
J Pharm Biomed Anal; 2010 Apr; 51(5):1069-77. PubMed ID: 20036089
[TBL] [Abstract][Full Text] [Related]
4. Permeability of lipophilic compounds in drug discovery using in-vitro human absorption model, Caco-2.
Krishna G; Chen K; Lin C; Nomeir AA
Int J Pharm; 2001 Jul; 222(1):77-89. PubMed ID: 11404034
[TBL] [Abstract][Full Text] [Related]
5. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
6. Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers.
Ingels F; Beck B; Oth M; Augustijns P
Int J Pharm; 2004 Apr; 274(1-2):221-32. PubMed ID: 15072798
[TBL] [Abstract][Full Text] [Related]
7. A systematic evaluation of solubility enhancing excipients to enable the generation of permeability data for poorly soluble compounds in Caco-2 model.
Shah D; Paruchury S; Matta M; Chowan G; Subramanian M; Saxena A; Soars MG; Herbst J; Haskell R; Marathe P; Mandlekar S
Drug Metab Lett; 2014; 8(2):109-18. PubMed ID: 25429513
[TBL] [Abstract][Full Text] [Related]
8. Impact of extracellular protein binding on passive and active drug transport across Caco-2 cells.
Neuhoff S; Artursson P; Zamora I; Ungell AL
Pharm Res; 2006 Feb; 23(2):350-9. PubMed ID: 16388407
[TBL] [Abstract][Full Text] [Related]
9. Addition of Optimized Bovine Serum Albumin Level in a High-Throughput Caco-2 Assay Enabled Accurate Permeability Assessment for Lipophilic Compounds.
Cai X; Madari S; Walker A; Paiva A; Li Y; Herbst J; Shou W; Weller H
SLAS Discov; 2019 Aug; 24(7):738-744. PubMed ID: 31076010
[TBL] [Abstract][Full Text] [Related]
10. Transport of a novel anti-cancer agent, fenretinide across Caco-2 monolayers.
Kokate A; Li X; Jasti B
Invest New Drugs; 2007 Jun; 25(3):197-203. PubMed ID: 17146731
[TBL] [Abstract][Full Text] [Related]
11. Use of simulated intestinal fluid for Caco-2 permeability assay of lipophilic drugs.
Fossati L; Dechaume R; Hardillier E; Chevillon D; Prevost C; Bolze S; Maubon N
Int J Pharm; 2008 Aug; 360(1-2):148-55. PubMed ID: 18539418
[TBL] [Abstract][Full Text] [Related]
12. Intestinal permeability study of minoxidil: assessment of minoxidil as a high permeability reference drug for biopharmaceutics classification.
Ozawa M; Tsume Y; Zur M; Dahan A; Amidon GL
Mol Pharm; 2015 Jan; 12(1):204-11. PubMed ID: 25423288
[TBL] [Abstract][Full Text] [Related]
13. In vitro system to evaluate oral absorption of poorly water-soluble drugs: simultaneous analysis on dissolution and permeation of drugs.
Kataoka M; Masaoka Y; Yamazaki Y; Sakane T; Sezaki H; Yamashita S
Pharm Res; 2003 Oct; 20(10):1674-80. PubMed ID: 14620525
[TBL] [Abstract][Full Text] [Related]
14. Caco-2 cells, biopharmaceutics classification system (BCS) and biowaiver.
Smetanová L; Stĕtinová V; Svoboda Z; Kvetina J
Acta Medica (Hradec Kralove); 2011; 54(1):3-8. PubMed ID: 21542416
[TBL] [Abstract][Full Text] [Related]
15. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs.
Dahan A; Amidon GL
Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230
[TBL] [Abstract][Full Text] [Related]
16. Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells.
Yamashita S; Furubayashi T; Kataoka M; Sakane T; Sezaki H; Tokuda H
Eur J Pharm Sci; 2000 May; 10(3):195-204. PubMed ID: 10767597
[TBL] [Abstract][Full Text] [Related]
17. Transport of cosalane-a highly lipophilic novel anti-HIV agent-across caco-2 cell monolayers.
Pal D; Udata C; Mitra AK
J Pharm Sci; 2000 Jun; 89(6):826-33. PubMed ID: 10824142
[TBL] [Abstract][Full Text] [Related]
18. Development of a more rapid, reduced serum culture system for Caco-2 monolayers and application to the biopharmaceutics classification system.
Lentz KA; Hayashi J; Lucisano LJ; Polli JE
Int J Pharm; 2000 Apr; 200(1):41-51. PubMed ID: 10845684
[TBL] [Abstract][Full Text] [Related]
19. Nano-reservoir Bioadhesive Tablets Enhance Protein Drug Permeability Across the Small Intestine.
Yin L; Wang Y; Wang C; Feng M
AAPS PharmSciTech; 2017 Aug; 18(6):2329-2335. PubMed ID: 28116599
[TBL] [Abstract][Full Text] [Related]
20. Provisional classification and in silico study of biopharmaceutical system based on caco-2 cell permeability and dose number.
Pham-The H; Garrigues T; Bermejo M; González-Álvarez I; Monteagudo MC; Cabrera-Pérez MÁ
Mol Pharm; 2013 Jun; 10(6):2445-61. PubMed ID: 23675957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
